LitAlert ~~ GeneLit.com

    • Preclinical and clinical evidence of Lurbinectedin in ovarian cancer: current status and future perspectives.
    • Musacchio L, Cicala CM, Salutari V, Camarda F, Carbone MV, Ghizzoni V, Giudice E, Nero C, Perri MT, Ricci C, Tronconi F, Scambia G, Lorusso D.
    • Front Oncol. 2022 Feb 1;10:831612. doi: 10.3389/fonc.2022.831612.
    • Case series: 'Aggressive HRD-positive colorectal cancer related to a BRCA1 pathogenic germline variant in young patients'.
    • Freire Chadrina MV, Martin M, Thissen R, Van Marcke C, Segers K, Sépulchre E, Leroi N, Lété C, Fasquelle C, Radermacher J, Gokburun Y, Collignon J, Sacré A, Josse C, Palmeira L, Vincent B.
    • Front Oncol. 2022 Feb 1;10:835581. doi: 10.3389/fonc.2022.835581.
    • Ovarian toxicity of carboplatin and paclitaxel in mouse carriers of mutation in BRIP1 tumor suppressor gene.
    • Ntemou E, Vidal PD, Alexandri C, Van den Steen G, Lambertini M, Demeestere I.
    • Sci Rep. 2022 Feb 1;12(1):1658. doi: 10.1038/s41598-022-05357-x.
    • When to Use Germline Genetic Testing in Prostate Cancer.
    • Giri VN.
    • Clin Adv Hematol Oncol. 2022 Feb;20(2).
    • Efficacy and safety of olaparib according to age in BRCA1/2-mutated patients with recurrent platinum-sensitive ovarian cancer: Analysis of the phase III SOLO2/ENGOT-Ov21 study.
    • Trillsch F, Mahner S, Ataseven B, Asher R, Aryal N, Dubot C, Clamp A, Penson RT, Oza A, Amit A, Huzarski T, Casado A, Scambia G, Friedlander M, Colombo N, Fujiwara K, Sonke GS, Denys H, Lowe ES, Lee CK, Pujade-Lauraine E.
    • Gynecol Oncol. 2022 Jan 31:S0090-8258(22)00050-6. doi: 10.1016/j.ygyno.2022.01.024. Epub ahead of print.
    • Germline Variants in DNA Damage Repair Genes: An Emerging Role in the Era of Precision Medicine in Pancreatic Adenocarcinoma.
    • Shoucair S, Baker AR, Yu J.
    • Ann Gastroenterol Surg. 2021 Sep 29 [2022 Jan];6(1):7-16. doi: 10.1002/ags3.12514. eCollection 2022 Jan.
    • So-Called Serous Carcinoma of the Uterine Cervix with BRCA2 Mutation: Case Report and Review of the Literature.
    • Herrera Gómez RG, Hastir D, Liapi A, Dolcan A, Herrera FG, Mathevet P, Sarivalasis A.
    • Case Rep Oncol. 2021 Dec 20;14(3):1792-1798. doi: 10.1159/000520429.